CVnCoV – CureVac AG vs placebo
Serious adverse eventsk
CVnCoV – CureVac AG showed no clear difference in serious adverse eventsk compared with placebo (low certainty).
1 finding from 1 review
- RR 1.24 [0.9, 1.71]1 study · 39529 participantsLow
CVnCoV – CureVac AG showed no clear difference in serious adverse eventsk compared with placebo (low certainty).